There are 410 resources available
Moving EGFR and ALK TKIs into earlier stage disease
Presenter: Margarita Majem Tarruella
Session: EGFR mutations and ALK rearrangements: Where are we now and where do we need to go to optimize treatment paradigms for our patients?
Resources:
Slides
Webcast
Value of genotyping in the assessment of minimum residual disease
Presenter: Luis Paz-Ares
Session: Genotyping in NSCLC: Monitoring, germline alterations, minimal residual disease
Resources:
Slides
Webcast
Language and its role in health equity
Presenter: Torsten Blum
Session: Language is more than words (Patient advocacy session)
Resources:
Slides
Webcast
Beyond ex19del and L858R: Update on EGFRex20 insertions and other uncommon EGFR mutations
Presenter: Xiuning Le
Session: EGFR mutations and ALK rearrangements: Where are we now and where do we need to go to optimize treatment paradigms for our patients?
Resources:
Slides
Webcast
The importance of a collaborative global effort among National and International Societies
Presenter: Vincent Fang
Session: Mediastinal tumours
Resources:
Slides
Webcast
Q&A
Presenter: Heather Wakelee
Session: EGFR mutations and ALK rearrangements: Where are we now and where do we need to go to optimize treatment paradigms for our patients?
Resources:
Webcast
Q&A
Presenter: Anne-Marie Baird
Session: Genotyping in NSCLC: Monitoring, germline alterations, minimal residual disease
Resources:
Webcast
Q&A and discussion
Presenter: Diego Villalon
Session: Language is more than words (Patient advocacy session)
Resources:
Webcast
Q&A
Presenter: Enrico Ruffini
Session: Mediastinal tumours
Resources:
Webcast
Introduction by the Chairs
Presenter: Noemi Reguart Aransay
Session: Air pollution and lung cancer
Resources:
Webcast